Literature DB >> 961849

Arachidonic acid in splanchnic artery occlusion shock.

G A Bridenbaugh, J T Flynn, A M Lefer.   

Abstract

Arachindonic acid infused into the mesenteric vascular bed of normal pentobarbital-anesthetized dogs at a concentrations of 150 mug/kg per min produced no significant changes in mean arterial blood pressure (MABP), portal vein pressure (PVP), screen filtration pressure (SFP), platelet count, circulating lysosomal enzyme or myocardial depressant factor (MCF) activities, nad only modestly increased superior mesenteric arter flow (SMAF)ans endogenous prostaglandin concentrations concentrations. It is concluded that arachidonic acid, at the infusion rate employed, dose not have any major effect on the circulatory status or on the lysosomal or platelet stability in normal dogs. In contrast, arachidonic acid administered to dogs in splanchnic artery occulusion (SAO) shock significantly exacerbated the decline in MABP seen after release of the occlusive clamps and also significantly reduced mesenteric blood flow. The hypothnsive of arachidonic acid appears to be partly due to the fatty acid itself and partly due to the metavolically formed prostaglandin endoct the platelet count or aggregability, lysosomal hydrolase activity, or MDF formation in the SAO shock dogs. These data suggest that increased endogenous prostaglandin concentrations in themselves are not a prime factor in the pathophysiology of circulatory shock, but that endogenous prostaglandin or related substances can significantly modulate the shock state.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961849     DOI: 10.1152/ajplegacy.1976.231.1.112

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.

Authors:  H Bitterman; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

2.  Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity.

Authors:  A M Lefer; G L Stahl; D J Lefer; M E Brezinski; K C Nicolaou; C A Veale; Y Abe; J B Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Beneficial effect of anisodamine in hemorrhagic shock.

Authors:  J Su; C E Hock; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

4.  Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.

Authors:  A M Lefer; E W Polansky; C P Bianchi; S Narayan
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

5.  Salutary effects of two verapamil analogs in traumatic shock.

Authors:  C E Hock; J S Daitch; A M Lefer
Journal:  Pharm Res       Date:  1985-05       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.